CTS Corporation (CTS) Income Statement

The gross margin trajectory is unambiguously positive: the company crossed the 40% threshold in 2026Q2 and sustained it in 2026Q3, suggesting the diversification strategy away from commoditized automotive sensing is gaining structural traction. However, the margin has not been monotonic—2025Q1 dipped to 36.5% before recovering sharply—indicating some vulnerability to input cost swings or utilization variability at its ceramic manufacturing facilities. The persistence of this expansion above 41% in the two most recent quarters would need to be validated against raw material cost trends for silver and palladium before being underwritten as a durable structural shift.

The sequential revenue progression from $125.8M in 2025Q1 to $149.6M in 2026Q3 represents an 18.9% cumulative increase over six quarters, which suggests the design win pipeline in medical and industrial applications may be converting into realized revenue. However, the deceleration from 10.9% growth in 2026Q1 to 4.4% in 2026Q3 introduces uncertainty about whether near-term demand pull-forward effects are masking a softer underlying run rate. The reported TTM revenue of $542.2M versus the latest quarter's $564.0M annualized equivalent raises questions about sustainability that warrant close monitoring.

While gross profit grew meaningfully over the ten-quarter window, operating margin has oscillated between 12.8% and 18.5% without a clear upward break, suggesting overhead scaling is consuming a disproportionate share of incremental gross profit. The SG&A ratio deterioration is particularly notable because it accelerated in 2026Q3 even as revenue reached a ten-quarter high, which may indicate rising sales and marketing investment to penetrate medical and aerospace channels or potential operational inefficiencies. Unless SG&A growth moderates relative to top-line expansion, the company may struggle to convert further gross margin improvement into proportional operating income gains.